Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ZYME

Zymeworks (ZYME)

Zymeworks Inc
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:ZYME
일자시간출처헤드라인심볼기업
2023/06/3005:12Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/06/2205:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ZYMEZymeworks Inc
2023/06/1305:26Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NYSE:ZYMEZymeworks Inc
2023/06/1305:07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/06/0519:03Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/06/0308:23PR Newswire (US)Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract CancersNYSE:ZYMEZymeworks Inc
2023/05/1821:41Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/05/1621:31Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/05/0906:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:ZYMEZymeworks Inc
2023/05/0905:14Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/04/2905:18Edgar (US Regulatory)Amended Annual Report (10-k/a)NYSE:ZYMEZymeworks Inc
2023/04/2621:31Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/04/1105:46Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/03/1605:17Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/03/1506:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ZYMEZymeworks Inc
2023/03/0807:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NYSE:ZYMEZymeworks Inc
2023/03/0806:09Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/02/1506:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ZYMEZymeworks Inc
2023/02/1506:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ZYMEZymeworks Inc
2023/02/1504:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ZYMEZymeworks Inc
2023/02/1107:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:ZYMEZymeworks Inc
2023/01/2522:30Business WireZymeworks Announces Participation in Upcoming Investor ConferencesNYSE:ZYMEZymeworks Inc
2023/01/2408:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ZYMEZymeworks Inc
2023/01/1922:11Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/01/1921:45PR Newswire (US)Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal AdenocarcinomaNYSE:ZYMEZymeworks Inc
2023/01/1921:45PR Newswire (US)Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal AdenocarcinomaNYSE:ZYMEZymeworks Inc
2023/01/1306:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ZYMEZymeworks Inc
2023/01/0506:22Edgar (US Regulatory)Current Report Filing (8-k)NYSE:ZYMEZymeworks Inc
2023/01/0506:15Business WireZymeworks Provides Corporate Update on Key Strategic Priorities and Outlook for 2023NYSE:ZYMEZymeworks Inc
2023/01/0407:02Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:ZYMEZymeworks Inc
 검색 관련기사 보기:NYSE:ZYME